ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of Alzheimer's disease based on wavelet transformation energy feature of the structural MRI image and NN classifier

Feng, Jinwang; Zhang, Shao-Wu*; Chen, Luonan*西北工业大学; 中国科学院研究生院; 中国科学院
Artificial Intelligence in Medicine2020-8DOI: 10.1016/j.artmed.2020.101940
15被引2阅读
引用收藏
分享

摘要

Alzheimer's disease (AD) is now difficult to be identified for clinicians, especially, at its prodromal stage, mild cognitive impairment (MCI), because of no obvious clinical symptom and few impacts on daily life at this phase. In addition, energy distribution differences of brain atrophies reflected in structural magnetic resonance imaging (sMRI) images between MCI patients and older healthy controls (HC) are minimal and subtle, which are difficult to be captured by the spatial analysis. In this study, we propose a novel method (namely AD-WTEF) to identify AD and MCI patients from HC subjects by extracting the wavelet transformation energy feature (WTEF) of the sMRI image. AD-WTEF firstly transforms each scan of the preprocessed sMRI image by wavelet to obtain its directional subbands with the same size at different transformation levels. And then, based on the anatomical automatic labeling (AAL) atlas, AD-WTEF constructs a new brain mask to segment the subbands at the same direction and transformation level into different energy regions of interest (EROIs). Thirdly, by averaging coefficients in an EROI, AD-WTEF gets an energy feature, following that energy features of different EROIs are connected to form an energy feature vector for describing the subbands at the same direction and transformation level. As a result, these energy feature vectors are further concatenated to be a WTEF of the sMRI image. Finally, the nearest neighbor (NN) classifier is selected and used for AD identification. Compared with other seven stateof-the-art methods, our AD-WTEF can effectively identify AD patients using the subtle energy distribution differences of sMRI images. Furthermore, experimental results indicate that our AD-WTEF can also find important brain ROIs related to AD.

学科与关键词

关键词
Alzheimer's diseaseImage classificationWavelet transformationFeature extractionEnergy feature
相关
加载中…
  • A review on Alzheimer?s disease classification from normal controls and mild cognitive impairment using structural MR images
    Garg, Neha*; Choudhry, Mahipal Singh; Bodade, Rajesh M.Journal of Neuroscience Methods, 2023, 384: 109745.被引 19
  • Alzheimer's disease diagnosis on structural MR images using circular harmonic functions descriptors on hippocampus and posterior cingulate cortex
    Ben Ahmed, Olfa*; Mizotin, Maxim; Benois-Pineau, Jenny; Allard, Michele; Catheline, Gwenaelle; Ben Amar, ChokriCOMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2015, 44: 13-25.被引 71
  • A novel method for the classification of Alzheimer's disease from normal controls using magnetic resonance imaging
    Khan, Riyaj Uddin; Tanveer, Mohammad*; Pachori, Ram BilasEXPERT SYSTEMS, 2021, 38(1).被引 24
查看全部 →

发表信息

论文状态
公开发表
期刊
Artificial Intelligence in Medicine
发表日期
2020-08
卷期
第 108 卷
页码
101940
DOI
10.1016/j.artmed.2020.101940
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [61873202, 31930022, 61473232, 91430111, 31771476, 81471047, 11871456]; National Key RD Program [2017YFA0505500, 2016YFC0903400]; Chinese Academy of Sciences [XDB38040400]; Natural Science Foundation of Shanghai [17ZR1446100]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research

作者

  • F

    Feng, Jinwang (第一作者)

    northwestern polytech univ

  • Z

    Zhang, Shao-Wu (通讯)

    northwestern polytech univ

查看全部 3 位作者收起作者
  • C

    Chen, Luonan (通讯)

    chinese acad sci · shanghai inst biochem & cell biol · northwestern polytech univ · univ chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417